Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
Stock Information for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Loading
Please wait while we load your information from QuoteMedia.